Hoffman and Abeloff's Hematology-Oncology Review - 1st Edition - ISBN: 9780323429757, 9780323443197

Hoffman and Abeloff's Hematology-Oncology Review

1st Edition

Authors: Claudine Isaacs Sanjiv Agarwala Bruce Cheson Alice Ma John Marshall Naiyer Rizvi
eBook ISBN: 9780323443197
eBook ISBN: 9780323443180
Paperback ISBN: 9780323429757
Imprint: Elsevier
Published Date: 16th November 2017
Page Count: 400

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.


For those preparing for certification or recertification in hematology or oncology, Hoffman and Abeloff's Hematology-Oncology Review is a single-volume source of authoritative, up-to-date exam preparation. This unique question and answer review helps you succeed on today’s board exams with more than 1,000 board-style questions, answers, and rationales; comprehensive coverage of essential exam topics, and online practice tests.

Key Features

  • Includes 1,000+ board-style questions with answers and rationales explaining both correct and incorrect answers.
  • Features three online practice tests per specialty that follow the ABIM exams blueprint, ensuring that complex content is delivered in easily digestible segments for more efficient review.
  • Covers a broad range of topics compiled by experts in hematology and oncology, including cancer biology and genomics, immunotherapy, hematologic malignancies, solid tumor malignancies, non-malignant hematology, and supportive care.
  • Uniquely designed as both a standalone review and a study companion to Abeloff’s Clinical Oncology and Hematology: Basic Principles and Practice.
  • Expert Consult™ eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, and references from the book on a variety of devices.

Table of Contents

Isaacs: Hoffman and Abeloff's Hematology-Oncology Review


1. Cancer biology and Genomics

2. Tumor Immunology

3. Anti-Cancer Therapies

 SECTION 1: Chemotherapy

SECTION 2: Immunotherapy, antibodies, vaccines and pathway inhibitors

4. Clinical Trial Design and Ethics

5. Hereditary Cancer Syndromes


6. Acute Myeloid Leukemia and Myelodysplastic Syndrome  

7. Myeloproliferative Disorders

8. Chronic Lymphocytic Leukemia, Hairy Cell Leukemia, and other Chronic Lymphoproliferative Disorders

9: Hodgkin lymphoma  

10. Non-Hodgkin Lymphoma

11. Multiple myeloma and other plasma cell dyscrasias

12. T cell and NK cell neoplasms and other lymphoid malignancies

13. Hematopoeietic Cell Transplantation  


14. Breast cancer  

a: Early Stage Breast Cancer

b: Metastatic breast cancer

e. Premalignant breast conditions and in situ disease

15. Lung Cancer

a: Non-small cell lung cancer 

b: Small cell lung cancer  

16. Other Thoracic Malignancies

a: Mesothelioma

b: Thymoma and thymic cancer

17. Head and Neck cancer 

18 : Esophageal Cancer

19: Gastric cancer

20: Pancreatic cancer

21: Colorectal cancer and Anal Cancer

22: Hepatobiliary cancer

23: Neuroendocrine, small bowel and appendiceal malignancies

24. Prostate cancer

25. Bladder and other urothelial cancers

26. Renal Carcinomas

27. Germ cell tumors

28. Gynecological Malignancies  

  1. Ovarian Cancer and Fallopian Tube Cancer
  2. Cancer of the Cervix, Uterus, Vagina, Vulva and Gestational Choriocarcinoma

29. Melanoma and other skin cancers

30. Bone and soft tissue sarcoma  

31.Cancer of unknown primary site

32. . Malignancies of the Central Nervous System

a. Primary

b. Metastatic


33. Coagulation  

34. Hematopoietic System    

1: Hematopoietic System Disorders RBC or iron

35. Transfusion Medicine  


Chapter 36. Supportive Care


No. of pages:
© Elsevier 2018
eBook ISBN:
eBook ISBN:
Paperback ISBN:

About the Author

Claudine Isaacs

Sanjiv Agarwala

Bruce Cheson

Alice Ma

John Marshall

Naiyer Rizvi